Nuformix (LSE:NFX) Other Stockholders Equity : £4.98 Mil (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Other Stockholders Equity?

Nuformix's Other Stockholders Equity for the quarter that ended in Sep. 2022 was £4.98 Mil.

Nuformix's quarterly Other Stockholders Equity increased from Sep. 2021 (£4.96 Mil) to Mar. 2022 (£4.97 Mil) and increased from Mar. 2022 (£4.97 Mil) to Sep. 2022 (£4.98 Mil).

Nuformix's annual Other Stockholders Equity increased from Mar. 2020 (£4.76 Mil) to Mar. 2021 (£4.95 Mil) and increased from Mar. 2021 (£4.95 Mil) to Mar. 2022 (£4.97 Mil).

Nuformix Other Stockholders Equity Historical Data

The historical data trend for Nuformix's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Other Stockholders Equity Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Other Stockholders Equity

Get a 7-Day Free Trial

3.67

4.65

4.76

4.95

4.97

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Other Stockholders Equity	Get a 7-Day Free Trial									4.95	4.96	4.97	4.98	4.99

Nuformix Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Nuformix Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nuformix's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.